Mutations in rhodopsin cause retinitis pigmentosa in humans and retinal degeneration in a multitude of other animals. We utilized high-resolution live imaging of the large rod photoreceptors from transgenic frogs (Xenopus) to compare the properties of fluorescently tagged rhodopsin, Rho-EGFP, and Rho P23H -EGFP. The mutant was abnormally distributed both in the inner and outer segments (OS), accumulating in the OS to a concentration of ,0.1% compared to endogenous opsin. Rho P23H -EGFP formed dense fluorescent foci, with concentrations of mutant protein up to ten times higher than other regions. Wild-type transgenic Rho-EGFP did not concentrate in OS foci when co-expressed in the same rod with Rho P23H -EGFP. Outer segment regions containing fluorescent foci were refractory to fluorescence recovery after photobleaching, while foci in the inner segment exhibited recovery kinetics similar to OS regions without foci and Rho-EGFP. The Rho P23H -EGFP foci were often in older, more distal OS disks. Electron micrographs of OS revealed abnormal disk membranes, with the regular disk bilayers broken into vesiculotubular structures. Furthermore, we observed similar OS disturbances in transgenic mice expressing Rho P23H , suggesting such structures are a general consequence of mutant expression. Together these results show that mutant opsin disrupts OS disks, destabilizing the outer segment possibly via the formation of aggregates. This may render rods susceptible to mechanical injury or compromise OS function, contributing to photoreceptor loss.
Introduction
The most common allele in North America for autosomal dominant retinitis pigmentosa, a major cause of retinal degeneration and vision loss worldwide [1] , is a missense mutation (P23H) in the gene encoding rhodopsin [2] . The molecular pathophysiology that leads to eventual photoreceptor death is unclear. The accumulation of misfolded Rho P23H in the endoplasmic reticulum was proposed to cause cellular stress [3] , however strong support in photoreceptors is lacking. A common feature of mechanisms proposed to explain cell loss in retinitis pigmentosa (RP) is misfolded protein retention and eventual aggregation in the endoplasmic reticulum (ER) inducing severe cellular stress [4] . In several different cultured mammalian cell lines [3, 5] , Rho P23H was prominent in the cytoplasm and formed aggregates resembling inclusion bodies and aggresomes similar to those described in other diseases such as cystic fibrosis (CFTR) and the early-onset familial Alzheimer's disease (PS1) [6] . Rho P23H causes loss of rods and retinal degeneration in many different animal models including mouse [7] [8] [9] , rat [10, 11] , pig [12] , frog [13] and even in flies [14] . A serious complication is the gene dosage effect, since relative protein levels of Rho P23H and wild type rhodopsin influence rod degeneration [7, 13, 15] . Studies of the pathogenic mechanism have focused on the cellular distribution of Rho P23H . In some animal models, rhodopsin has been found in both inner and outer segments [13, 15] , although this has not been observed in Rho P23H knock-in mice [9] . All animal models show a disturbance of the OS in terms of length, with eventual OS disorganization as rods die. However, the cause of the cellular toxicity has not been identified. We have investigated whether protein aggregates, the central premise of pathological mechanism in neurodegenerative diseases [16] , occur in rods expressing Rho P23H . We have quantified the distribution and properties of a Rho P23H -EGFP fusion protein in transgenic Xenopus, a system wellsuited for live cell imaging. Focusing on rods with low fluorescent protein expression levels has allowed us to characterize primary properties of the mutant protein and avoid the complications of overexpression.
Results and Discussion
Quantitative analysis of Rho-EGFP and Rho P23H -EGFP distributions in transgenic Xenopus rods showed a marked difference between the two fusion proteins (Fig. 1,2,3 and Fig.  S1 ). Rho-EGFP localized primarily in the OS of mature rods, while Rho P23H -EGFP was distributed in both OS and inner segments (IS), localizing around the nucleus and more diffusely in the ellipsoid and myoid areas but not in the synaptic region. The retinal phenotype from the Rho P23H -EGFP depended strongly on the expression level of the transgene, with the most severe effects in those retina with highest concentration of Rho P23H -EGFP in rods prior to degeneration (Fig. S1 , see also [13] ). These include shortening and loss of the OS, mislocalization in the IS and abnormal shedding events. In order to investigate the intrinsic properties of Rho P23H -EGFP in non-degenerating rods, we focused on those transgenic animals with expression levels that were less than ,5% of the endogenous level in both primary transgenic animals and different transgenic lines (Table 1) . We note that there was a significant attenuation of Rho P23H -EGFP expression levels over several weeks in all animals. This reduction in expression level was not accompanied by a loss in rod number. Comparable reduction in transgene expression was not observed in animals expressing either Rho-EGFP (Fig. S1 ) or even soluble EGFP (data not shown) even though expression levels were much higher.
To directly compare the behavior of Rho and Rho P23H in the same cell, transgenic animals were produced using dual transgene expression constructs consisting of two rhodopsin cassettes in tandem. Both Rho-EGFP and Rho-mCherry exhibited a regular transverse banding in the OS (Fig. 2a, d ) that is related to the diurnal variation in rhodopsin density in the OS membranes (Haeri et al., in preparation) . However, mutant opsin exhibited abnormal foci that contained high concentrations of fluorescent mutant protein in both the IS and OS (Fig. 2b ). Foci were observed independent of the fluorescent protein fused to its carboxyl terminus (EGFP, Fig. 2 and mCherry, Fig. S5 ). The wild type protein did not show a co-concentration with the mutant fluorescent foci (Fig. 2d) . Rods expressing Rho P23H -EGFP imaged along the axial length of the OS showed fluorescent foci in the mid-periphery of OS disks (Fig. 2f) . This is in contrast to the behavior of Rho-EGFP that was found throughout the axial optical section (Fig. 2f) , but was typically at much reduced concentration in disk incisures (Fig. S4 ). This reduction of Rho P23H -EGFP from disk incisures was not observed (Fig. 2 ).
Quantitative analysis of fluorescent protein concentrations strongly suggests that foci formation is specific to the mutant protein, since the concentration of Rho P23H -EGFP is much lower than the coexpressed wild type transgene (Figs. 2 and 3) and endogenous rhodopsin (Table 1) . It is important to note that although the transcript levels for Rho P23H -EGFP and co-expressed RhomCherry are very similar (Fig. S2) , the protein concentrations are very different (Table 1 and Fig. 3 ). Thus, there is either increased protein degradation or decreased translation of the Rho P23H -EGFP transcript, or both, in mutant-expressing rods. A similar finding has been reported for knock-in Rho P23H mice [9] . Daily membrane biosynthesis adds approximately 80 disks at the base of Xenopus OS every day, which is equivalent to ,1.2 mm in OS length [17] . Thus, the OS contains a record of the rhodopsin biosynthesis over more than 4 weeks, with the oldest disks at the apical end. We quantified the number of foci in two regions of the OS, base and central. We restricted the analysis to the proximal half of the OS to minimize in vitro artifacts introduced by OS damage, e.g. breakage or swelling. There were a highly variable number of foci found per OS, from absent to more than 20. It is important to note that the experiments reported here did not characterize fluorescent foci less than 0.4 mm. The foci had different shapes and sizes, but it was possible to count the number of distinct foci per OS. We found more fluorescent foci in the central region than in the basal region, i.e. in older OS membranes (Fig. 2e) . These results suggest that the probability of forming foci or having them reach a detectable size may be a slow process.
We used fluorescent recovery after photobleaching (FRAP) in live retinal explants expressing Rho P23H -EGFP to characterize the mobility of the protein within the fluorescent foci. Both soluble EGFP and Rho-EGFP (Fig. 4) exhibited a single component fluorescence recovery profile after photobleaching expected for a mobile protein [18] . Since Rho-EGFP is restricted to movement within the disk, lateral recovery is the dominant factor in the FRAP signal. Thus, this diffusion occurs in the plane of the disk membrane and fluorescence recovery after photobleaching arises from fluorescent proteins diffusing laterally into the photobleached area. Under these experimental conditions, photobleaching of the targeted area (white box in Fig. 4 b-f ) takes several seconds. The diffusion of fluorescent rhodopsin is rapid enough so that a decrease in the fluorescence density (,30%) of the unbleached, laterally adjacent area is observed in the first scans after photobleaching (Fig. 4g , neighboring area). We note that the images are confocal scans from the photobleached optical plane; lateral (Fig. 1 ). To facilitate comparison between the rates of fluorescence recovery in these regions, we normalized the relative fluorescence changes in the photobleached areas (Fig. 4h) . The average FRAP profile of Rho P23H -EGFP at the base of OS, where dense protein foci were not detectable, was similar to the profile found for Rho-EGFP (Fig. 4h) . Moreover, the IS foci (Fig. 4d) had a fluorescence recovery in the photobleached area (Fig. 4h) and a decrement of fluorescence in the neighborhood of the photobleached area (Fig. 4d ) similar to Rho-EGFP. These results show that, at least in photoreceptors, the Rho P23H -EGFP within IS foci is similar to wild type protein and more mobile than expected for protein found in aggresomes [3] .
By contrast, areas with fluorescent foci in the OS showed no recovery from photobleaching (Fig. 4e, i) , even though the foci were bleached in a way that left adjacent fluorescent regions intact. We found that highly fluorescent foci adjacent to a photobleached area did not exhibit any decrease in fluorescence, i.e. fluorescent protein in the foci was not able to move to a neighboring areas (Fig. 4e, i) . These results indicate that the foci in the OS and IS have disparate physical properties and highlight that Rho P23H - EGFP has inherent mobility similar to Rho-EGFP when not found in fluorescent foci. This suggests either a change over time or in the cellular environment that causes the mutant protein to become immobile, e.g. aggregation or disk membrane breakdown. Cells expressing Rho P23H -EGFP with fluorescent foci often exhibited disturbances of the OS in differential interference contrast micrographs (Fig. 5a, d) . The disturbances coincided with foci (Fig. 5b, e) and were not observed in OS containing Rho-EGFP or Rho P23H -EGFP without foci. OS morphology of transgenic animals that express Rho-EGFP was indistinguishable from non-transgenic animals, exhibiting many closely stacked disks in electron micrographs (Fig. 5f ). However, OS containing mutant opsin had vesiculotubular structures (VT) between 50-400 nm in diameter in a single section (Fig. 5h, i) . The continuity of underlying disk membranes was totally disrupted around the VTs (Fig. 5i ). These were observed in 11 of the 70 cells examined from 4 animals. During preparation for electron microscopy, tissue damage sometimes occurred, causing breaks or distortions in the outer segment (Fig. 5g) . These defects were distinct and easily distinguished from the VTs. We also examined a mouse line containing a Rho P23H transgene [8] and found similar VT structures (Fig. 5l, m) . These results provide strong evidence for a common process underlying OS disruption in vertebrates. Furthermore, they suggest that Rho P23H functions at low concentrations compared to wild type protein, catalyzing local changes in disk membranes, possibly through homo-oligomerization. Future work should be directed toward establishing a molecular mechanism for this process.
Previous work has reported disruptions of degenerating OS in mice expressing a Rho P23H transgene [7] [8] [9] . Abnormal OS membranes are also formed in Xenopus retina treated with tunicamycin [19] and in rats deprived of vitamin A [20] . However, the underlying causes have not been established. This report established that low level expression of mutant opsin leads to a destructive effect on disk membranes via subcellular microstructures. We hypothesize that the mutant protein undergoes self-aggregation with age (Fig. 6) . Apparently, either the Rho P23H -EGFP is not present in the IS long enough to form immobile aggregates or there are factors not present in the OS that prevent their formation. It is possible that misfolded opsin, i.e. protein that cannot bind 11-cis retinal, is responsible for fluorescent foci formation. However, since Rho P23H retains the ability to bind 11-cis retinal [21] , additional experiments using other mutants with more severe defects (e.g. Rho C187R -EGFP) will be necessary to clarify this point. Our results highlight that even with a robust protein quality control response that leads to a decrease in mutant protein expression, small amounts of mutant protein that escape the ER and are transported to the OS can have a deleterious effect on the cell. As such, this report proposes a novel mechanism for the toxic effect of opsin mutants. The damaged disk membranes are potentially more susceptible to mechanical injury or instability, resulting in their collapse.
Autosomal dominant RP is a slow disease [22] , in which rods may up-regulate the UPR [4] and degrade mutant opsin (including aggregates in the IS). However, over time, some mutant opsin may escape to the OS and undergo a time-dependent aggregation leading to VT formation. Daily disk shedding will remove defective membrane and reduce potential toxicity, acting as another quality control step. Eventually, VTs may persist and cause mechanical breakdown. This process of membrane destabilization may also be relevant to Alzheimer's disease and other common neurodegenerative diseases [16] .
Materials and Methods

Transgenic animals
Animals expressing rhodopsin transgenes in rods were produced by restriction enzyme mediated integration into Xenopus sperm -EGFP transgenic animals exhibited vesiculotubular structures (h, i, arrowheads) of similar size to the fluorescent foci found in CSLM imaging. These structures were not observed in micrographs from Rho-EGFP transgenic animals (f). Mechanical disruption of retina prior to fixation (g) showed OS breaks and disk membrane separations but no vesiculotubular structures. Micrographs from four animals were examined for each group. (j-m) Electron micrographs of retina from wild-type (j) or Rho P23H (GHL) transgenic mice (l). Membranes from Rho P23H transgenic animals exhibited vesiculotubular structures (m, arrowheads). Vesiculotubular structures were not observed in micrographs from wild type animals (j, k). Scale bars, 100 nm (g, i, k, m), 200 nm (f, h) and 2 mm (j, l). doi:10.1371/journal.pone.0030101.g005 nuclei as previously described with modifications [23] [24] [25] [26] . Plasmids containing transgenes were linearized with XhoI or NheI (New England Biolabs) and purified prior to injection. GFP expression in live tadpoles was estimated using a fluorescence dissecting microscope (Leica MZ FL III) and divided into three intensity groups (bright, medium and faint) according to an arbitrary scale based upon photographic exposure times, using soluble GFP for comparison. Animals were maintained on a 12 h-12 h light-dark cycle at 18-20uC. All animal handling and experiments were in agreement with the animal care and use guidelines of the Association for Research in Vision and Ophthalmology (ARVO). This study was done under the approval of the SUNY Upstate Medical University Committee on the Human Use of Animals (CHUA no. 209).
Transgenic DNA constructs
The Rho-EGFP cDNA encoded amino acids 1-354 of Xenopus rhodopsin [27] fused in frame with EGFP followed by the 1D4 epitope (ETSQVAPA) [28] at the carboxyl terminus [29] . Mutations were introduced into the Rho-EGFP cDNA using QuikChange II XL (Stratagene). The promoter used in all experiments was a fragment containing nucleotides 2503 to +41 from the Xenopus opsin (XOP) gene [31] . Dual transgene expression constructs consisted of two XOP(2503/+41)-Rho-EGFP/mCherry (or Rho P23H -EGFP/mCherry) cassettes in tandem. All protein coding regions were sequenced on both strands and then linearized with XhoI or NheI prior to transgenesis.
Immunohistochemistry and electron microscopy
For immunohistochemistry, eyes were fixed in 4% paraformaldehyde in PBS at 4uC and frozen in OCT (TissueTek Inc.).
Frozen blocks were sectioned at 12-20 mm slices with a Microm 560 cryostat (Richard Allen Scientific) and immunostained with primary antibody overnight at 4uC, washed and then incubated with appropriate conjugated secondary antibody. Primary antibodies used were mouse anti-rhodopsin 4D2 (1:3000) and antimouse secondary antibody (Jackson ImmunoResearch) conjugated to Cy3 (1:500). Slides were examined with the i-80 series (Nikon) or LSM-510 confocal microscopes (Zeiss). For preparation of EM sections, eyes were fixed in 2.5% glutaraldehyde and 1% OsO4 and embedded in epoxy resin.
Total RNA extraction and qPCR
Six retina without retinal pigmented epithelium were isolated and used for total RNA extraction. cDNA was generated using QuantiTect TM Reverse Transcription Kit (Qiagen) and real time PCR was performed using SYBR Green MasterMix I and the LightCyclerH 480 Real-Time PCR System (Roche Applied Science). Data were analyzed by the LightCyclerH software and plotted using Sigmaplot (Systat).
Live cell imaging
The recording chamber was made in the center of a 5 cm plastic Petri dish as described previously [30] . The bottom of the chamber was comprised of a number 1 coverslip attached to the bottom of the chamber permitting the access of the microscope lenses. Retinal explants were minced into small pieces and placed into the chamber with Ringer's solution (in mM: NaCl 111, KCl 2, CaCl 2 1, MgCl 2 1, MgSO 4 0.5, NaH 2 PO 4 0.5, HEPES 3, glucose 10, EDTA 0.01). The chamber was then covered by a number 1 coverslip and placed onto the microscope stage for imaging. For quantification of foci, seven tadpoles from two transgenic lines 
Quantification of proteins by confocal microscopy
Images for quantification of transgenic proteins expressed in rod photoreceptors were acquired using the LSM-510 software driving a confocal LSM-510 imaging system (Zeiss). Retinal explants were immersed in frog Ringer's solution and scanned by a laser line of 488 or 543 nm. The scanning objective for both channels was a Plan-Neofluar 636/1.4 oil lens (Zeiss). To minimize the bleeding through channels, the emitted light from 488 nm excitation was filtered by a 500-535 nm filter, and the emitted light from the 543 nm excitation was filtered by a 655-710 band pass filter. The resolution of all scanned images was set to 0.0460.04 mm in the xy plane. At least 5 z scans from the central area of the rod photoreceptor with a 0.5 mm interval were obtained. The LSM-510 software was set to correct for the z plane while scanning dual channels. The pixel time, pinhole diameter, amplifier offset and amplifier gain for all scans were set to 3 ms, 1.4 airy units, 0.1 and 1, respectively. Recombinant EGFP and mCherry at different concentrations were scanned at the same settings used for retinal explant imaging (Fig. S3 ).
Image analysis for protein quantification
Fluorescent intensities of images were measured using AxioVision TM software version 4.7 (Zeiss), corrected for the background intensity, and averaged values of at least three z sections were used for protein measurements. The measured fluorescent intensities were converted to protein concentration using values obtained from scanned fluorescent solutions containing known concentrations of recombinant fluorescent proteins (Fig. S3) .
FRAP analysis by confocal microscopy
For acquisition of images in FRAP experiments the LSM software version 2.8 was used to drive a LSM-510 confocal microscope. Retinal explants were prepared as previously described and imaged using a Plan-Neofluar 636/1.4 oil lens (Zeiss). The laser line for scanning with 488 nm light powered by an Argon laser was set at 21 milliwatt. The laser power for image acquisition before and after photobleaching was set to 0.5-4% of the maximum laser power and to 100% during photobleaching. The recording chamber was initially searched for retinal explants having rods which were parallel with the covering coverslip. A single rod photoreceptor was centered in the imaging window and 8 bit images in gray scale 255 were scanned usually from a square, 13.2613.2 mm in xy plane, or 2566256 pixels. The photobleaching was performed in the central part of the OS or within dense fluorescent foci found in the IS in a rectangular region 1.8 mm in diameter and usually for 40 ms/mm 2 per iteration. The laser scanning performed before photobleaching, during photobleaching and after, was in the same z axis. The images in the recovery phase were taken right after photobleaching and then every 3-5 seconds in time series of at least 25 recovery scans. FRAP data were analyzed using AxioVision TM software version 4.7 (Zeiss) and SigmaPlot TM (Systat Software Inc.). Briefly, the images were corrected for background fluorescence and the averaged intensity of the selected area was measured (AxioVision TM ) and plotted. The averaged intensity of the recovering area was normalized to the non-bleached neighboring area in each scanned image. The time for recovery to 50% of maximum fluorescence (t 1/2 ) was measured by fitting a one parameter exponential function using SigmaPlot. The error bars show the SEM. 
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